Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss

Tracy, Tara E., Sohn, Peter Dongmin, Minami, S. Sakura, Wang, Chao, Min, Sang-Won, Li, Yaqiao, Zhou, Yungui, Le, David +7 more·2016·Neuron

Cited by (281)

Items 101–200 of 281

  1. Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities
    Meilan Hu, Fu-le He, Erik W. Thompson, Kostya Ostrikov, Xiaofeng Dai · 2022 · Cancers
  2. Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
    Trae Carroll, Sanjib K Guha, Keith W. Nehrke, Gail V.W. Johnson · 2021 · Biology
  3. Tau; One Protein, So Many Diseases
    Tabeshmehr, Parisa, Eftekharpour, Eftekhar · 2023 · Biology
  4. Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation
    Yuxing Xia, Brach M. Bell, Benoit I. Giasson · 2021 · Scientific Reports
  5. Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
    Marta Fernández‐Nogales, José J. Lucas · 2020 · Frontiers in Cellular Neuroscience
  6. Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders?
    Jens Stepan, Elmira A. Anderzhanova, Nils C. Gassen · 2018 · Frontiers in Psychiatry
  7. AMPK Ameliorates Tau Acetylation and Memory Impairment Through Sirt1
    Lin Wang, Fang-Xiao Shi, Na Li, Yun Cao, Ying Lei, Jian‐Zhi Wang, Qing Tian, Xinwen Zhou · 2020 · Molecular Neurobiology
  8. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation
    Deepa Ajit, Hanna Trzeciakiewicz, Jui‐Heng Tseng, Connor M. Wander, Youjun Chen, Aditi Ajit, Diamond P. King, Todd J. Cohen · 2019 · Journal of Biological Chemistry
  9. A potential biomarker of preclinical Alzheimer’s disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments
    Yan Yan, Ailikemu Aierken, Chunjian Wang, Da Feng Song, Junjun Ni, Zhe Wang, Zhenzhen Quan, Hong Qing · 2021 · Neuroscience & Biobehavioral Reviews
  10. SIRT2 as a potential new therapeutic target for Alzheimer’s disease
    Noemí Sola-Sevilla, Elena Puerta · 2023 · Neural Regeneration Research
  11. Microtubule-associated protein tau in murine kidney: role in podocyte architecture
    Laura Vallés‐Saiz, Rocio Peinado-Cahuchola, Jesús Ávila, Félix Hernández · 2022 · Cellular and Molecular Life Sciences
  12. The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases
    Haihui Liu, Si Xu, Chen Wang, Yu Lin Deng, Bin Xu, Tianyao Yang, Jingyi Sun, Wei Liu · 2022 · Neuroscience
  13. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
    Jie Yang, Naiting Shen, Jianying Shen, Ying Yang, Hong-Lian Li · 2023 · Molecular Neurobiology
  14. Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis
    Amir Zeb, Chanin Park, Shailima DV Rampogu, Minky Son, Gihwan Lee, Keun Woo Lee · 2018 · ACS Chemical Neuroscience
  15. Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
    Hai Yang, Jin‐Ping Li, Xiaoxiong Li, Linqiu Ma, Mingliang Hou, Huadong Zhou, Rui Zhou · 2022 · Frontiers in Molecular Neuroscience
  16. p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD
    Gong, Ping, Chen, Yan-qing, Lin, Ai-hua, Zhang, Hai-bo, Zhang, Yan, Ye, Richard D., Yu, Yang · 2020 · Alzheimer's Research & Therapy
  17. Sirtuins promote brain homeostasis, preventing Alzheimer’s disease through targeting neuroinflammation
    Mateusz Wątroba, Dariusz Szukiewicz · 2022 · Frontiers in Physiology
  18. Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunction
    Peter J. Teravskis, Breeta R. Oxnard, Eric C. Miller, Lisa J. Kemper, Karen H. Ashe, Dezhi Liao · 2019 · The Journal of Physiology
  19. The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?
    Peter J. Teravskis, Karen H. Ashe, Dezhi Liao · 2020 · The Neuroscientist
  20. Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
    Daniel C. Xu, Hanna Sas‐Nowosielska, Greg Donahue, Hua Huang, Naemeh Pourshafie, Charly Ryan Good, Shelley L. Berger · 2024 · Acta Neuropathologica Communications
  21. The role of lysine acetylation in metabolic sensing and proteostasis
    Aziz Eftekhari, Usman Sabir, Takhar Kasumov · 2025 · Pharmacology & Therapeutics
  22. The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA
    Jitendra Subhash Rane, Anuradha Ranjan Kumari, Dulal Panda · 2019 · ACS Chemical Neuroscience
  23. A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response
    Jui‐Heng Tseng, Aditi Ajit, Zarin Tabassum, Niyati Patel, Xu Tian, Youjun Chen, Alex W. Prevatte, Karen Ling, Frank Rigo, Rick B. Meeker et al. · 2020 · Cell Reports
  24. KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss
    Grant Kauwe, Kristeen A. Pareja-Navarro, Lei Yao, Jackson H. Chen, Ivy Wong, Rowan Saloner, Helen Cifuentes, Alissa L. Nana, Samah Shah, Yaqiao Li et al. · 2024 · Journal of Clinical Investigation
  25. Neogenin in Amygdala for Neuronal Activity and Information Processing
    Xiangdong Sun, Wenbing Chen, Dong Sun, Jie Huang, Yuan‐Quan Li, Jin‐Xiu Pan, Yanan Wang, Kai Zhao, Zhaoqi Dong, Hongsheng Wang et al. · 2018 · Journal of Neuroscience
  26. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models
    Song, Ha-Lim, Kim, Na-Young, Park, Jaewan, Kim, Meong Il, Jeon, Yu-Na, Lee, Se-Jong, Cho, Kwangmin, Shim, Young-Lim, Lee, Kyoung-Hye, Mun, Yeon-Seon et al. · 2023 · Journal of Clinical Investigation
  27. Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses
    Liqiu Wang, Mengqiu Li, Guang‐Yu Lian, Shuai Yang, Jing Cai, Zhe Cai, Yaoxing Wu, Jun Cui · 2024 · Journal of Clinical Investigation
  28. HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease
    Hailong Zhang, Shufen Hu, Pin Yang, Han-Chun Long, Quanhong Ma, Dong‐Min Yin, Guang‐Yin Xu · 2024 · CNS Neuroscience & Therapeutics
  29. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    C Bravo, Karen Krukowski, Sarah Barker, Chao Wang, Yaqiao Li, Li Fan, Edwin Vázquez‐Rosa, Min‐Kyoo Shin, Man Ying Wong, Louise D. McCullough et al. · 2024 · Molecular Neurodegeneration
  30. The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding
    Zhang, Haibo, Lin, Aihua, Gong, Ping, Chen, Yanqing, Ye, Richard D., Qian, Feng, Zhang, Yan, Yu, Yang · 2020 · The Journal of Neuroscience
  31. Sirtuin 3 Mediates Tau Deacetylation
    Shiping Li, Junxiang Yin, Megan Nielsen, Thomas G. Beach, Li Guo, Jiong Shi · 2019 · Journal of Alzheimer s Disease
  32. Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease
    Tenielle Porter, Victor L. Villemagne, Greg R. Savage, Lidija Milicic, Yen Ying Lim, Paul T. Maruff, Colin Louis Masters, David J. Ames, Ashley Ian Bush, Ralph Nigel Martins et al. · 2018 · Personalized Medicine in Psychiatry
  33. LTP-like plasticity is impaired in amyloid-positive amnestic MCI but independent of PET-amyloid burden
    Stephanie S. Buss, Daniel Zvi Press, Katherine McDonald, Erin G. Kitchener, Margaret G. O’Connor, Kevin J. Donohoe, Mouhsin M. Shafi, Álvaro Pascual‐Leone, Peter J. Fried · 2020 · Neurobiology of Aging
  34. A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors
    Aliki Drakontaeidi, Eleni A. Pontiki · 2023 · Pharmaceuticals
  35. Illuminating Neural Circuits in Alzheimer’s Disease
    Ying Yang, Jian‐Zhi Wang · 2021 · Neuroscience Bulletin
  36. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
    Mohammed Alrouji, Mohammed S. Alshammari, Tasqeeruddin Syed, Anas Shamsi · 2025 · Antioxidants
  37. Metabolic dysfunction and mitochondrial failure in Alzheimer's disease: integrating pathophysiology, clinical evidence and emerging interventions
    Xiaohua Xiao, Xueqin Yan, Chunhua Liang, Yunzhu Yang · 2026 · Frontiers in Neurology
  38. KIBRA regulates activity-induced AMPA receptor expression and synaptic plasticity in an age-dependent manner
    Matthew L. Mendoza, Lilyana D. Quigley, Thomas L. Dunham, Lenora J. Volk · 2022 · iScience
  39. Hippo-released WWC1 facilitates AMPA receptor regulatory complexes for hippocampal learning
    Jens Stepan, Daniel E. Heinz, Frederik Dethloff, Thomas Bajaj, Andreas Zellner, Kathrin Hafner, Svenja Wiechmann, Sarah Mackert, Yara Mecdad, Michael Rabenstein et al. · 2022 · Cell Reports
  40. Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
    Hyeanjeong Jeong, Seulgi Shin, Jun‐Seok Lee, Soo Hyun Lee, Ja‐Hyun Baik, Sungsu Lim, Yun Kyung Kim · 2019 · International Journal of Molecular Sciences
  41. Synaptic Localisation of Tau
    Diane P. Hanger, Despoina Goniotaki, Wendy J. Noble · 2019 · Advances in experimental medicine and biology
  42. Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction
    Giacomo Siano, Chiara Falcicchia, Nicola Origlia, Antonino Cattaneo, Cristina Di Primio · 2021 · International Journal of Molecular Sciences
  43. Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity
    Carli K. Opland, Miles R. Bryan, Braxton Harris, Jake McGillion-Moore, Xu Tian, Youjun Chen, Michelle S. Itano, Graham H. Diering, Rick B. Meeker, Todd J. Cohen · 2023 · iScience
  44. Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice
    Stepan, Jens, Heinz, Daniel E., Dethloff, Frederik, Wiechmann, Svenja, Martinelli, Silvia, Hafner, Kathrin, Ebert, Tim, Junglas, Ellen, Häusl, Alexander S., Pöhlmann, Max L. et al. · 2024 · Science Signaling
  45. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study
    Yu Feng Zou, Lulu Guan · 2021 · Frontiers in Molecular Biosciences
  46. Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
    Andrew W. Hwang, Hanna Trzeciakiewicz, Dave Friedmann, Chao‐Xing Yuan, Ronen Marmorstein, Virginia M.‐Y. Lee, Todd J. Cohen · 2016 · PLoS ONE
  47. Dementia Therapy Targeting Tau
    Luc Buée · 2019 · Advances in experimental medicine and biology
  48. “Cascaded Rocket” Nanosystems with Spatiotemporal Separation for Triple‐Synergistic Therapy of Alzheimer's Disease
    Ruiyuan Liu, Jun Yang, Xinyu Qiu, Weihong Ji, Jie Shen, Yan Li, Zhiguo Lü, Yanyue Wu, Wenli Wang, Jing Wang et al. · 2022 · Advanced Healthcare Materials
  49. WWC1/2 regulate spinogenesis and cognition in mice by stabilizing AMOT
    Runyi Cao, Rui Zhu, Zhao Sha, Sixian Qi, Zhenxing Zhong, Fengyun Zheng, Yubin Lei, Yanfeng Tan, Yuwen Zhu, Yu Wang et al. · 2023 · Cell Death and Disease
  50. Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors
    Michael O. Isei, Peter Girardi, Joel Rodwell‐Bullock, Keith W. Nehrke, Gail V.W. Johnson · 2023 · Journal of Neurochemistry
  51. T217-Phosphorylation Exacerbates Tau Pathologies and Tau-Induced Cognitive Impairment
    Xin Wang, Qian Rong Liu, Xiaoguang Li, Qiuzhi Zhou, Dongqin Wu, Shihong Li, Yanchao Liu, Jian‐Zhi Wang · 2021 · Journal of Alzheimer s Disease
  52. Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer’s disease pathology
    Jun‐Ping Pan, Ping-Jie Wang, Jianying Zhang, Anne‐Brita Knapskog, Leiv Otto Watne, He-Ling Wang, Mariá José Lagartos-Donate, Sofie Lautrup, Li-Peng Mao, Qian Wang et al. · 2026 · Nature Aging
  53. Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice
    Xin Wang, En-Jie Liu, Qian Rong Liu, Shihong Li, Ting Li, Qiuzhi Zhou, Yanchao Liu, Huaqiu Zhang, Jian‐Zhi Wang · 2020 · Journal of Alzheimer s Disease
  54. Regulation of Tau Homeostasis and Toxicity by Acetylation
    Tara E. Tracy, Kathryn C. Claiborn, Li Gan · 2019 · Advances in experimental medicine and biology
  55. Neural changes in Alzheimer’s disease from circuit to molecule: Perspective of optogenetics
    Qinghu Yang, Da Feng Song, Hong Qing · 2017 · Neuroscience & Biobehavioral Reviews
  56. Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer’s Disease
    Feixuan Wu, Wei Li, Haiyan Lu, Lingjun Li · 2025 · Molecular & Cellular Proteomics
  57. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
  58. Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease
    Tong Zhang, Amalia M. Dolga, Ulrich L.M. Eisel, Martina Schmidt · 2023 · Neurobiology of Disease
  59. PACAP: A promising disease-modifying target for Alzheimer's disease
    Rehana Basri, Hayder Mutter Al-Kuraishy, Mohamed N Fawzy, Mubarak Alruwaili, Gaber El‐Saber Batiha · 2025 · Life Sciences
  60. Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins
    Kaitlin Blackstone Casaletto, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, William G. Honer, Julie A. Schneider, David Alan Bennett, Nina A. Djukic, Michelle Y. You, Sophia Weiner‐Light et al. · 2021 · Neurology
  61. In‐depth analysis of the Sirtuin 5‐regulated mouse brain malonylome and succinylome using library‐free data‐independent acquisitions
    Joanna Bons, Jacob Rose, Ran Zhang, Jordan B. Burton, Christopher Carrico, Eric M. Verdin, Birgit Schilling · 2022 · PROTEOMICS
  62. In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein
    Yong‐Chan Kim, Byung‐Hoon Jeong · 2019 · Current Alzheimer Research
  63. Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice
    Anjanet R. Loon, Frank Zamudio, Awa Sanneh, Breanna Brown, Shayna Smeltzer, Milene Lara Brownlow, Zainuddin Quadri, Melinda M. Peters, Edwin J. Weeber, Kevin R. Nash et al. · 2021 · GeroScience
  64. KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment
    Salvatore Mazzeo, Valentina Bessi, Sonia Padiglioni, Silvia Bagnoli, Laura Bracco, Sandro Sorbi, Benedetta Nacmias · 2019 · Neurological Sciences
  65. RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
    Mennatallah O. Zaki, S. El-Desouky, Doaa A. Elsherbiny, Mohamed Salama, Samar S. Azab · 2022 · Inflammopharmacology · Retracted
  66. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
    Jun‐Fei Zhang, Zhi‐Ting Fang, Jun‐Ning Zhao, Gong‐Ping Liu, Xin Shen, Gaofeng Jiang, Qian Rong Liu · 2024 · Journal of Neurochemistry
  67. TauP301L disengages from the proteosome core complex and neurogranin coincident with enhanced neuronal network excitability
    Katriona L. Hole, Bangfu Zhu, Laura Huggon, Jon T. Brown, Jody M. Mason, Robert J. Williams · 2024 · Cell Death and Disease
  68. Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?
    Neng‐Wei Hu, Zhengtao Hu, Tomáš Ondrejčák, Pengpeng Yu, Yangyang Zhang, Yin Yang, Igor V. Klyubin, Seán Kennelly, Michael J. Rowan · 2022 · Neural Regeneration Research
  69. K v 1.1 preserves the neural stem cell pool and facilitates neuron maturation during adult hippocampal neurogenesis
    Yuan-Hung Lin King, Chao Chen, John V. Lin King, Jeffrey A. Simms, Edward Glasscock, Shi‐Bing Yang, Yuh Nung Jan, Lily Yeh Jan · 2022 · Proceedings of the National Academy of Sciences
  70. The Hippo signaling pathway as a therapeutic target in Alzheimer’s disease
    Doris Chen, Stella Wigglesworth-Littlewood, Frank J. Gunn‐Moore · 2025 · Molecular Neurodegeneration
  71. Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease
    Zahra Farajzadeh Vahid, Morteza Eskandani, Hamed Dadashi, Somayeh Vandghanooni, Mohammad‐Reza Rashidi · 2024 · Heliyon
  72. The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
    Oksana Fihurka, Yuzhu Hong, Jiyu Yan, Breanna Brown, Xiaoyang Lin, Ning Shen, Yanhong Wang, Haohan Zhao, Marcia N. Gordon, David Morgan et al. · 2022 · International Journal of Molecular Sciences
  73. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
    Florence Haut, Elentina K. Argyrousi, Ottavio Arancio · 2023 · International Journal of Molecular Sciences
  74. Distinctive phosphoinositide- and Ca2+-binding properties of normal and cognitive performance–linked variant forms of KIBRA C2 domain
    Mareike G. Posner, Abhishek Kumar Upadhyay, Rieko Ishima, Antreas C. Kalli, Gemma Harris, Joachim Kremerskothen, Mark S.P. Sansom, S.J. Crennell, Stefan Bagby · 2018 · Journal of Biological Chemistry
  75. KIBRA and APOE Gene Variants Affect Brain Functional Network Connectivity in Healthy Older People
    Dawei Wang, Li Hu, Xinghua Xu, Xiangxing Ma, Yi Li, Yong Liu, Qing Wang, Chuanjun Zhuo · 2019 · The Journals of Gerontology Series A
  76. WWC1 mutation drives dopamine dysregulation and synaptic imbalance in Tourette’s syndrome
    Junkai Lv, Shaoyan Liang, Pengwei Qin, Xinlu Liu, Xiangyu Ge, Yiqing Guo, Shili Xia, Wei Jing, Youming Lu, Tongmei Zhang et al. · 2025 · Science Advances
  77. Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimer's Oscillatory Biomarkers
    Roser Sanchez-Todo, Borja Mercadal, Edmundo Lopez-Sola, Maria Guasch-Morgades, Gustavo Deco, Giulio Ruffini · 2026 · Human Brain Mapping
  78. IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity
    Bilge Askin, Cagla Kilic, César Cordero Gómez, Sophie Lan-Linh Duong, Alvaro Dominguez‐Baquero, Alexander Goihl, Karsten Nalbach, Joana Petushi, Pia Grundschöttel, Jessica Wagner et al. · 2026 · Science Advances
  79. m6A Modification Involves in Enriched Environment-Induced Neurogenesis and Cognition Enhancement
    Wenzheng Qu, Qian Li, Mengxuan Wang, Xingsen Zhao, Jiangdong Wu, Diwen Liu, Shenghui Hong, Ying Yang, Qiang Shu, Xuekun Li · 2022 · Frontiers in Cell and Developmental Biology
  80. Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer’s Disease
    Ryszard M. Pluta, Sławomir Januszewski, Mirosław Jabłoński · 2022 · International Journal of Molecular Sciences
  81. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
  82. Neocortical tau propagation is a mediator of clinical heterogeneity in Alzheimer’s disease
    Anjalika Chongtham, Aarthi Ramakrishnan, Marissa Farinas, Diede W. M. Broekaart, Joon Ho Seo, Carolyn Wei Zhu, Mary Sano, Li Shen, Ana C. Pereira · 2025 · Molecular Psychiatry
  83. Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons
    Yoonah R. Oh, Min‐Kyoo Shin · 2025 · BMB Reports
  84. Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
    Michelle Diane Rudman, Jason D. Ulrich, David M. Holtzman · 2026 · Cell
  85. Experience alters hippocampal and cortical network communication via a KIBRA-dependent mechanism
    Lilyana D. Quigley, Robert Pendry, Matthew L. Mendoza, Brad E. Pfeiffer, Lenora J. Volk · 2023 · Cell Reports
  86. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease
    Miles R. Bryan, Xu Tian, Jui‐Heng Tseng, Baggio Evangelista, Joey V. Ragusa, Audra F. Bryan, Winifred Trotman, David John Irwin, Todd J. Cohen · 2024 · Acta Neuropathologica Communications
  87. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia
    Elizabeth L. Steuer, Lisa J. Kemper, Chris J.W. Hlynialuk, Kailee Leinonen-Wright, Michelle L. Montonye, Ian P. Lapcinski, Colleen L. Forster, Karen H. Ashe, Peng Liu · 2022 · Journal of Neuroscience
  88. Actin Cytoskeleton at the Synapse: An Alzheimer's Disease Perspective
    P A Haseena, Nimisha Basavaraju, Anant Gupta, Reddy Peera Kommaddi · 2025 · Cytoskeleton
  89. Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein
    Valeria Melissa García-Cruz, Roberto Coria, Clorinda Arias · 2025 · Molecular and Cellular Biochemistry
  90. Tau post-translational modifications in Alzheimer's disease: Insights into pathogenesis, therapeutic strategies, and diagnostic advances
    Hui Lei, Xiaohua Chen, Longzhu Ruan, Xuena Liu, Fei Ye, Kejing Li, Wei Cheng, Boyi Yu, Cuixia Di, Cuixia Di · 2025 · Ageing Research Reviews
  91. Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders
    Fei Tang, Junfen Wei, Ma-Li Wong, Peng Lei · 2025 · Genomic psychiatry :
  92. Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease
    Pramod Gudigenahally Nagaraju, Ashwini S, Poornima Priyadarshini C. G. · 2022 · Critical Reviews in Food Science and Nutrition
  93. A heterobifunctional molecule system for targeted protein acetylation in cells
    Liyun Chen, Wei Wang, Jacob M. Wozniak, Christopher G. Parker · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
  94. Unique expression pattern of KIBRA in the enteric nervous system of APP/PS1 mice
    Jianli Feng, Lingling Dong, Jing Zhang, Xiaolei Han, Shi Hui Tang, Lin Song, Lin Cong, Xiang Wang, Yongxiang Wang, Yifeng Du · 2018 · Neuroscience Letters
  95. Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation
    Ethan D. Smith, Jose Torrellas, Robert McKenna, Quan Vo, Mario Mietzsch, David Borchelt, Stefan Prokop, Paramita Chakrabarty · 2025 · Journal of Neurochemistry
  96. A T231E Mutant that Mimics Pathologic Phosphorylation of Tau in Alzheimer’s disease Causes Activation of the Mitochondrial Unfolded Protein Response in C. elegans touch neurons
    Sanjib K Guha, Sarah Fischer, Anson Cheng, Gail V.W. Johnson, Keith W. Nehrke · 2020 · PubMed Central
  97. Intersection of Redox Chemistry and Ubiquitylation: Post-Translational Modifications Required for Maintaining Cellular Homeostasis and Neuroprotection
    Emma I. Kane, Kelly L. Waters, Donald E. Spratt · 2021 · Cells
  98. Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach
    Asha Anand, Powsali Ghosh, Ravi Singh, Nilesh Gajanan Bajad, Ashok Kumar, Sushil Kumar Singh · 2023 · Journal of Biomolecular Structure and Dynamics
  99. FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility
    Yue Li, Wenxin Ma, Ruishuang Ma, Shuang Wang, Xu Liu, Xiaomeng Guo, Wenhua Li, Xiaopeng Chen, Yuan‐Lu Cui, Song He · 2025 · Cell Death and Differentiation
  100. The medial septum-hippocampus-lateral septum circuitry in spatial memory: linking healthy function to early Alzheimer’s disease and translational opportunities
    Yujie Song, Junjun Ni, Hong Qing, Zhenzhen Quan · 2025 · Translational Neurodegeneration